single nucleotide variant | NM_007294.4(BRCA1):c.441+2T>G | BRCA1 | Pathogenic | 17 | 41256137 | 41256137 | A | C | reviewed by expert panel | ClinGen:CA10581605 |
Duplication | NM_007294.4(BRCA1):c.64_65dup (p.Leu22fs) | BRCA1 | Pathogenic | 17 | 41276048 | 41276049 | T | TAA | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA1):184&base_change=ins TT,ClinGen:CA003777 |
single nucleotide variant | NM_000077.5(CDKN2A):c.260G>C (p.Arg87Pro) | CDKN2A | Pathogenic/Likely pathogenic | 9 | 21971098 | 21971098 | C | G | criteria provided, multiple submitters, no conflicts | ClinGen:CA10582653,UniProtKB:P42771#VAR_001451 |
Deletion | NM_000077.5(CDKN2A):c.150+1del | CDKN2A | Likely pathogenic | 9 | 21974676 | 21974676 | AC | A | criteria provided, single submitter | ClinGen:CA10582656 |
single nucleotide variant | NM_000077.5(CDKN2A):c.95T>C (p.Leu32Pro) | CDKN2A | Pathogenic/Likely pathogenic | 9 | 21974732 | 21974732 | A | G | criteria provided, multiple submitters, no conflicts | ClinGen:CA10582657,UniProtKB:P42771#VAR_001416 |
Deletion | NM_000059.4(BRCA2):c.342_343del (p.His114fs) | BRCA2 | Pathogenic | 13 | 32899237 | 32899238 | CAT | C | reviewed by expert panel | ClinGen:CA10583065 |
single nucleotide variant | NM_000059.4(BRCA2):c.1189C>T (p.Gln397Ter) | BRCA2 | Pathogenic | 13 | 32906804 | 32906804 | C | T | reviewed by expert panel | ClinGen:CA10583071 |
single nucleotide variant | NM_000059.4(BRCA2):c.2095C>T (p.Gln699Ter) | BRCA2 | Pathogenic | 13 | 32910587 | 32910587 | C | T | reviewed by expert panel | ClinGen:CA10583077 |
single nucleotide variant | NM_000059.4(BRCA2):c.2239G>T (p.Glu747Ter) | BRCA2 | Pathogenic | 13 | 32910731 | 32910731 | G | T | reviewed by expert panel | ClinGen:CA10583079 |
Deletion | NM_000059.4(BRCA2):c.3349del (p.Ile1117fs) | BRCA2 | Pathogenic | 13 | 32911841 | 32911841 | TA | T | reviewed by expert panel | ClinGen:CA10583088 |